• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AI-SONICTM甲状腺系统与六种甲状腺癌风险分层指南在乳头状甲状腺癌中的对比分析:一项回顾性队列研究

Comparative Analysis of AI-SONICTM Thyroid System and Six Thyroid Risk Stratification Guidelines in Papillary Thyroid Cancer: A Retrospective Cohort Study.

作者信息

Wang Mingyan, Yang Siyuan, Yang Linxin, Lin Ning

机构信息

Ultrasound Department of Shengli Clinical Medical College of Fujian Medical University, Fuzhou City, Fujian Province, 350001, People's Republic of China.

Ultrasound Department of Fujian Provincial Hospital, Fuzhou City, Fujian Province, 350001, People's Republic of China.

出版信息

Ther Clin Risk Manag. 2024 Aug 23;20:515-528. doi: 10.2147/TCRM.S458576. eCollection 2024.

DOI:10.2147/TCRM.S458576
PMID:39193477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11348989/
Abstract

AIM

The study aimed to compare the diagnostic performance of AI-SONICTM Thyroid System (AI-SONICTM) with six thyroid nodule ultrasound risk stratification systems, as well as the interobserver agreement among different-year ultrasound examiners using the same diagnostic approach.

METHODS

This retrospective study included patients who underwent thyroid ultrasound examination and surgery between 2010 and 2022. Three ultrasound examiners with 2, 5, and 10 years of experience, respectively, used AI-SONICTM and six guidelines to risk-stratify the nodules. The diagnostic performance and interobserver agreement were assessed.

RESULTS

A total of 370 thyroid nodules were included, including 195 papillary thyroid carcinomas (PTC) and 175 benign nodules. For physicians of varying seniority from low to high, AI-SONICTM had a moderate sensitivities of 82.56%, 83.08%, 84.62%, respectively, while AACE/ACE/AME had the highest diagnostic sensitivities (96.41%, 95.38%, 96.41%, respectively); And relatively higher specificities were 85.14%, 85.71%, 85.71% for KSThR, while moderate specificities with values of 84.0%, 85.14%, and 85.71%, respectively were found for AI-SONICTM; The accuracy was highest for ATA (excluding non-classifiable nodules), with values of 87.26%, 87.93%, and 88.82%, respectively, while the accuracy for AI-SONICTM were 83.24%, 84.05%, and 85.14%, respectively. The Kendall's tau coefficient indicated strong or moderate interobserver agreement among all examiners using different diagnostic methods (Kendall's tau coefficient >0.6, P<0.001). AI-SONICTM showed the highest interobserver agreement (Kendall's tau coefficient=0.995, P<0.001). A binary probit regression analysis showed that nodules with cystic components had a significantly higher regression coefficient value of 0.983 (P=0.002), indicating that AI-SONICTM may have higher accuracy for nodules with cystic components.

CONCLUSION

AI-SONICTM and the six thyroid nodule ultrasound risk stratification systems showed high diagnostic performance for papillary thyroid carcinoma. All examiners showed strong or moderate interobserver agreement when using different diagnostic methods. AI-SONICTM may have higher accuracy for nodules with cystic components.

摘要

目的

本研究旨在比较AI-SONIC™甲状腺系统(AI-SONIC™)与六种甲状腺结节超声风险分层系统的诊断性能,以及不同年份的超声检查人员使用相同诊断方法时的观察者间一致性。

方法

这项回顾性研究纳入了2010年至2022年间接受甲状腺超声检查和手术的患者。三位分别具有2年、5年和10年经验的超声检查人员使用AI-SONIC™和六种指南对结节进行风险分层。评估了诊断性能和观察者间一致性。

结果

共纳入370个甲状腺结节,其中包括195个甲状腺乳头状癌(PTC)和175个良性结节。对于资历从低到高的医生,AI-SONIC™的敏感性分别为中等的82.56%、83.08%、84.62%,而美国临床内分泌医师协会/美国内分泌学会/美国医学内分泌学会(AACE/ACE/AME)具有最高的诊断敏感性(分别为96.41%、95.38%、96.41%);KSThR的特异性相对较高,分别为85.14%、85.71%、85.71%,而AI-SONIC™的特异性为中等,分别为84.0%、85.14%和85.71%;美国甲状腺协会(ATA)(不包括不可分类的结节)的准确性最高,分别为87.26%、87.93%和88.82%,而AI-SONIC™的准确性分别为83.24%、84.05%和85.14%。肯德尔tau系数表明,使用不同诊断方法的所有检查人员之间存在强或中等的观察者间一致性(肯德尔tau系数>0.6,P<0.001)。AI-SONIC™表现出最高的观察者间一致性(肯德尔tau系数=0.995,P<0.001)。二元概率回归分析表明,具有囊性成分的结节的回归系数值显著更高,为0.983(P=0.002),表明AI-SONIC™对于具有囊性成分的结节可能具有更高的准确性。

结论

AI-SONIC™和六种甲状腺结节超声风险分层系统对甲状腺乳头状癌显示出较高的诊断性能。所有检查人员在使用不同诊断方法时均表现出强或中等的观察者间一致性。AI-SONIC™对于具有囊性成分的结节可能具有更高的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b5/11348989/828a34e4b21f/TCRM-20-515-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b5/11348989/36d06928077f/TCRM-20-515-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b5/11348989/e97ca8dd6fda/TCRM-20-515-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b5/11348989/828a34e4b21f/TCRM-20-515-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b5/11348989/36d06928077f/TCRM-20-515-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b5/11348989/e97ca8dd6fda/TCRM-20-515-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b5/11348989/828a34e4b21f/TCRM-20-515-g0003.jpg

相似文献

1
Comparative Analysis of AI-SONICTM Thyroid System and Six Thyroid Risk Stratification Guidelines in Papillary Thyroid Cancer: A Retrospective Cohort Study.AI-SONICTM甲状腺系统与六种甲状腺癌风险分层指南在乳头状甲状腺癌中的对比分析:一项回顾性队列研究
Ther Clin Risk Manag. 2024 Aug 23;20:515-528. doi: 10.2147/TCRM.S458576. eCollection 2024.
2
Diagnostic efficiency of existing guidelines and the AI-SONIC™ artificial intelligence for ultrasound-based risk assessment of thyroid nodules.现有指南和 AI-SONIC™人工智能在基于超声的甲状腺结节风险评估中的诊断效率。
Front Endocrinol (Lausanne). 2023 Feb 15;14:1116550. doi: 10.3389/fendo.2023.1116550. eCollection 2023.
3
Inter- and Intraobserver Agreement in the Assessment of Thyroid Nodule Ultrasound Features and Classification Systems: A Blinded Multicenter Study.甲状腺结节超声特征和分类系统评估的观察者间和观察者内一致性:一项盲法多中心研究。
Thyroid. 2020 Feb;30(2):237-242. doi: 10.1089/thy.2019.0360.
4
Clinical Evaluation of an Artificial Intelligence-Based Decision Support System for the Diagnosis and American College of Radiology Thyroid Imaging Reporting and Data System Classification of Thyroid Nodules.基于人工智能的决策支持系统在甲状腺结节诊断和美国放射学院甲状腺影像报告和数据系统分类中的临床评估。
Thyroid. 2024 Apr;34(4):510-518. doi: 10.1089/thy.2023.0603. Epub 2024 Mar 19.
5
A Multidisciplinary Head-to-Head Comparison of American College of Radiology Thyroid Imaging and Reporting Data System and American Thyroid Association Ultrasound Risk Stratification Systems.美国放射学院甲状腺影像报告数据系统与美国甲状腺协会超声风险分层系统的多学科头对头比较。
Oncologist. 2020 May;25(5):398-403. doi: 10.1634/theoncologist.2019-0362. Epub 2019 Nov 19.
6
The Added Value of Operator's Judgement in Thyroid Nodule Ultrasound Classification Arising From Histologically Based Comparison of Different Risk Stratification Systems.基于组织学的不同风险分层系统比较得出的甲状腺结节超声分类中操作者判断的附加价值。
Front Endocrinol (Lausanne). 2020 Jul 7;11:434. doi: 10.3389/fendo.2020.00434. eCollection 2020.
7
Diagnostic Performance of Ultrasound-Based Risk-Stratification Systems for Thyroid Nodules: Comparison of the 2015 American Thyroid Association Guidelines with the 2016 Korean Thyroid Association/Korean Society of Thyroid Radiology and 2017 American College of Radiology Guidelines.基于超声的甲状腺结节风险分层系统的诊断性能:2015 年美国甲状腺协会指南与 2016 年韩国甲状腺协会/韩国甲状腺放射学会和 2017 年美国放射学会指南的比较。
Thyroid. 2018 Nov;28(11):1532-1537. doi: 10.1089/thy.2018.0094.
8
Predictive Value of Malignancy of Thyroid Nodule Ultrasound Classification Systems: A Prospective Study.甲状腺结节超声分类系统恶性预测价值的前瞻性研究。
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1359-1368. doi: 10.1210/jc.2017-01708.
9
Retrospective analysis of the ultrasound features of resected thyroid nodules.切除甲状腺结节的超声特征回顾性分析。
Endocrine. 2021 May;72(2):486-494. doi: 10.1007/s12020-020-02495-y. Epub 2020 Oct 2.
10
Malignancy risk stratification and FNA recommendations for thyroid nodules: A comparison of ACR TI-RADS, AACE/ACE/AME and ATA guidelines.甲状腺结节的恶性风险分层和 FNA 建议:ACR TI-RADS、AACE/ACE/AME 和 ATA 指南的比较。
Am J Otolaryngol. 2020 Nov-Dec;41(6):102625. doi: 10.1016/j.amjoto.2020.102625. Epub 2020 Jun 24.

本文引用的文献

1
Transformative potential of Artificial Intelligence in pharmacy practice.人工智能在药学实践中的变革潜力。
Saudi Pharm J. 2023 Sep;31(9):101706. doi: 10.1016/j.jsps.2023.101706. Epub 2023 Jul 22.
2
Artificial Intelligence in Thyroidology: A Narrative Review of the Current Applications, Associated Challenges, and Future Directions.人工智能在甲状腺学中的应用:当前应用、相关挑战及未来方向的叙述性综述。
Thyroid. 2023 Aug;33(8):903-917. doi: 10.1089/thy.2023.0132. Epub 2023 Jun 26.
3
Diagnostic efficiency of existing guidelines and the AI-SONIC™ artificial intelligence for ultrasound-based risk assessment of thyroid nodules.
现有指南和 AI-SONIC™人工智能在基于超声的甲状腺结节风险评估中的诊断效率。
Front Endocrinol (Lausanne). 2023 Feb 15;14:1116550. doi: 10.3389/fendo.2023.1116550. eCollection 2023.
4
Assessment of the statistical optimization strategies and clinical evaluation of an artificial intelligence-based automated diagnostic system for thyroid nodule screening.基于人工智能的甲状腺结节筛查自动化诊断系统的统计优化策略评估与临床评价
Quant Imaging Med Surg. 2023 Feb 1;13(2):695-706. doi: 10.21037/qims-22-85. Epub 2023 Jan 2.
5
Clinical Value of Artificial Intelligence-Based Computer-Aided Diagnosis System Versus Contrast-Enhanced Ultrasound for Differentiation of Benign From Malignant Thyroid Nodules in Different Backgrounds.基于人工智能的计算机辅助诊断系统与增强超声在不同背景下鉴别甲状腺良恶性结节的临床价值。
J Ultrasound Med. 2023 Aug;42(8):1757-1766. doi: 10.1002/jum.16195. Epub 2023 Feb 16.
6
Diagnostic Performance of Six Ultrasound Risk Stratification Systems for Thyroid Nodules: A Systematic Review and Network Meta-Analysis.六种甲状腺结节超声风险分层系统的诊断性能:系统评价和网络荟萃分析。
AJR Am J Roentgenol. 2023 Jun;220(6):791-803. doi: 10.2214/AJR.22.28556. Epub 2023 Feb 8.
7
Clinical evaluation of malignancy diagnosis of rare thyroid carcinomas by an artificial intelligent automatic diagnosis system.人工智能自动诊断系统对罕见甲状腺癌恶性诊断的临床评估
Endocrine. 2023 Apr;80(1):93-99. doi: 10.1007/s12020-022-03269-4. Epub 2022 Dec 3.
8
Diagnostic performance of six ultrasound-based risk stratification systems in thyroid follicular neoplasm: A retrospective multi-center study.六种基于超声的甲状腺滤泡性肿瘤风险分层系统的诊断性能:一项回顾性多中心研究。
Front Oncol. 2022 Oct 20;12:1013410. doi: 10.3389/fonc.2022.1013410. eCollection 2022.
9
Identification of benign and malignant thyroid nodules based on dynamic AI ultrasound intelligent auxiliary diagnosis system.基于动态 AI 超声智能辅助诊断系统的甲状腺良恶性结节鉴别。
Front Endocrinol (Lausanne). 2022 Sep 27;13:1018321. doi: 10.3389/fendo.2022.1018321. eCollection 2022.
10
Differentiated thyroid carcinoma: An update.分化型甲状腺癌:最新进展
Best Pract Res Clin Endocrinol Metab. 2023 Jan;37(1):101687. doi: 10.1016/j.beem.2022.101687. Epub 2022 Aug 12.